Novo Nordisk adds four registrations: new molecule trial, CagriSema switch study, real-world dataSep 30Weekly roundup, 7 itemsCagrisemaNNC0705-0002Updated
Novo Nordisk registers Phase 3 obesity trial in Japan; new CagriSema switch studySep 16Weekly roundup, 2 itemsCagrisemaNNC0487-0111
Sign inSign in